Blip

About this episode

Crystal Research Associates’ chief executive officer and cofounder, Jeffrey Kraws, was interviewed by Bloomberg Television today discussing recent progress with a potential HIV vaccine that is now in clinical testing as well as highlighting some of the issues facing the upcoming H1N1 flu vaccines. During the segment, Mr. Kraws noted recent advances that have been made in vaccine technologies, including those at biotechnology companies CEL-SCI Corporation (CVM-NYSE Amex), Generex Biotechnology Corporation (GNBT-NASDAQ), and Unilife Medical Solutions Limited (UNI-ASX), which could help supplement the research and development conducted by larger pharmaceutical companies.

• Release Date

  Sep 25, 2009

• Runtime

  00:42